Prescription medicine
Dextrose and lidocaine
Dextrose and lidocaine is a prescription medicine. No generic is listed in FDA's NDC Directory.
- No generic listed
Check it at the source: the dextrose and lidocaine FDA label on DailyMed (effective January 14, 2026, B. Braun Medical Inc.); every dextrose and lidocaine label on DailyMed.
Highlights of the record
FDA label of January 14, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026
Used for
From the label: indications and usageLidocaine hydrochloride administered intravenously is specifically indicated in the acute management of (1) ventricular arrhythmias occurring during cardiac manipulations, such as cardiac surgery and (2) life-threatening arrhythmias which are ventricular in origin, such as occur during acute myocardial infarction.
Forms and strengths
- 0.4 g/100ml / 5 g/100ml
- 0.8 g/100ml / 5 g/100ml
Injection (solution).
On the market
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 2 of which 0 under generic applications, 2 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- Not in the survey
- Shortage (FDA)
- None current 3 past records
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 177 through July 30, 2026
What is dextrose and lidocaine used for?
From the label: indications and usageLidocaine hydrochloride administered intravenously is specifically indicated in the acute management of (1) ventricular arrhythmias occurring during cardiac manipulations, such as cardiac surgery and (2) life-threatening arrhythmias which are ventricular in origin, such as occur during acute myocardial infarction.
FDA pharmacologic class: Amide Local Anesthetic and Antiarrhythmic.
Source: FDA drug label (Lidocaine Hydrochloride and Dextrose), B. Braun Medical Inc., effective January 14, 2026 (SPL set 7dff29d9-522d-40eb-a9d9-42377912d640), via openFDA; the full label on DailyMed
Is there a generic for dextrose and lidocaine?
No generic dextrose and lidocaine is approved (Drugs@FDA, October 8, 2026).
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
Is dextrose and lidocaine in shortage?
No dextrose and lidocaine presentation is listed as limited or unavailable in the FDA Drug Shortage Database (read October 8, 2026); it keeps 3 current entries listed as available (updated September 22, 2026). ASHP keeps a separate shortage list, which can differ.
| Presentation | Company | Status | Updated |
|---|---|---|---|
| Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10) | B. Braun Medical Inc. | Current | September 22, 2026 |
| Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20) | B. Braun Medical Inc. | Current | September 22, 2026 |
| Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20) | B. Braun Medical Inc. | Current | September 22, 2026 |
Every dextrose and lidocaine presentation in the FDA shortage database
Source: FDA Drug Shortage Database via openFDA, updated October 8, 2026
What does the dextrose and lidocaine label say about other medicines?
The dextrose and lidocaine label names 6 other medicines in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Amiodarone | drug interactions | When lidocaine is administered with other antiarrhythmic drugs such as phenytoin, procainamide, propranolol, amiodarone, or quinidine, the cardiac effects may be additive or antagonistic and toxic effects may be additive. |
| Cimetidine | drug interactions | Coadministration of propranolol or cimetidine with lidocaine has been reported to reduce clearance from the plasma and may result in toxic accumulation of the drug (see CLINICAL PHARMACOLOGY ). |
| Phenytoin | drug interactions | When lidocaine is administered with other antiarrhythmic drugs such as phenytoin, procainamide, propranolol, amiodarone, or quinidine, the cardiac effects may be additive or antagonistic and toxic effects may be additive. |
| Procainamide | drug interactions | When lidocaine is administered with other antiarrhythmic drugs such as phenytoin, procainamide, propranolol, amiodarone, or quinidine, the cardiac effects may be additive or antagonistic and toxic effects may be additive. |
| Propranolol | drug interactions | Coadministration of propranolol or cimetidine with lidocaine has been reported to reduce clearance from the plasma and may result in toxic accumulation of the drug (see CLINICAL PHARMACOLOGY ). |
| Quinidine | drug interactions | When lidocaine is administered with other antiarrhythmic drugs such as phenytoin, procainamide, propranolol, amiodarone, or quinidine, the cardiac effects may be additive or antagonistic and toxic effects may be additive. |
Source: FDA drug label (Lidocaine Hydrochloride and Dextrose), B. Braun Medical Inc., effective January 14, 2026 (SPL set 7dff29d9-522d-40eb-a9d9-42377912d640), via openFDA; the full label on DailyMed
What do FAERS reports show for dextrose and lidocaine?
The FDA Adverse Event Reporting System holds 177 reports that list dextrose and lidocaine among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 13 are coded as a death and 84 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Other amide local anesthetics
- the pharmacologic class, with prices and generics
- Dextrose and lidocaine side effects
- the label's list beside FAERS reports
- Dextrose and lidocaine shortage record
- every presentation, company and date
- Check an interaction
- what two or more labels say about each other